Take a look at the presentations of the main scientific sessions!

For all details about the speakers, sessions, oral abstract presentations, posters, and special sessions please check the iPlanner:


Please note: all times are shown in Central European Summer Time (CEST).

Wednesday, May 5, 2021


Pre-Meeting Symposium: Living Donor Transplantation: Beyond Surgery

Session 1: The LDLT Donor I

  • Accepting a steatotic right lobe living donor – Limits, preparation, and role of defatting cocktails
  • Safe use of low GRWR grafts
  • Debates in LDLT – Minimally invasive donor hepatectomy: Laparoscopic vs. robotic

Session 2: The LDLT Donor II

  • Complex biliary anatomy: Short- and long-term risks for the donor
  • Long term psychosocial follow-up of donors post donor hepatectomy: An essential aspect

Session 3: The LDLT Recipient I

  • Donor biliary problems, incidence, treatment, outcomes and preventions
  • Evaluation and selection of patients with tumours beyond conventional criteria (UCSF): Should the criteria be different for LDLT?
  • Debates in LDLT: Arterial reconstruction: Microscope vs. Loupes – Does it make a difference?
  • Debates in LDLT – What matters in Small for Size Syndrome in LDLT: Portal flow vs. pressure

Session 4: The LDLT Recipient II – Surgical Innovations in LDLT (Video Lectures)

  • Intraoperative management of PVT: Different scenarios, different solutions
  • Bench reconstruction of complex venous outflow
  • Multiple bile ducts: How to deal with them


Pathology Workshop

Oncology Section

  • Transplant oncology: Current status including tumor types and peri LT treatment, and future perspectives. What can a liver surgeon expect from a pathologist?
  • Tumor pathology of HCC, combined HCC-CCA, iCCA and metastatic tumor: Tumor diagnosis including diagnostic pitfalls, macro/micro classification and inter/intra tumoral heterogeneity
  • Chemotherapy-induced liver injury (steatohepatitis, NRH, SOS): Pathological features and clinical impact

Non-Oncology Section

  • Diagnosis and assessment of disease severity as well as post LT recurrence in chronic liver disease patients. What can a liver surgeon expect from a pathologist?
  • Chronic liver diseases (viral hepatitis, AIH, PSC, PBC) and acute liver failure in pre- and post-LT patients
  • Fatty liver diseases including (non) alcoholic- steatohepatitis : definition and pathological features in pre- and post-LT patients


Basic Science Workshop: From Clinical Liver Transplantation to Personalized Patient Care: Omics, Artificial Intelligence and Experimental Models

  • The A_B_C of liver transplant research: Starting a lab for liver transplantation research, from basic science to precision medicine
  • Basic science
  • Translational science
  • The multi-omics era: Identifying strategies that will benefit specific research questions in liver transplantation
  • Different omics strategies: Pros and cons
  • Big data analyses
  • What experimental models can I set up for personalized medicine?
  • Small animal models
  • Large animal models
  • New advances in liver transplantation science
  • How do I publish basic science papers in liver transplantation? – What is Transplantation Journal’s position as the official journal of ILTS to accept basic science papers?


Thursday, May 6, 2021


Featured Symposium: Anesthesia/Critical Care

  • Obesity and LT: New prospective
  • High-risk donor liver transplantation: Perioperative challenges and outcome
  • Sarcopenia and nutritional status in LT: Criteria for not pursuing transplantation
  • Cerebral hemodynamic in cirrhosis


Featured Symposium: Machine Perfusion: Do We Have the Answer?

  • Overview of current clinical machine perfusion strategies
  • General or selective use: Which grafts require machine perfusion?
  • Graft viability testing and treatment options during normothermic machine perfusion vs. hypothermic machine perfusion
  • The essentials for future clinical trial designs in machine perfusion


Vanguard Featured Symposium

  • Risk stratification and prediction of mortality in LT for ACLF
  • Preoperative organ optimization for neurological renal and pulmonary system before LT in ACLF
  • Living donor selection in high urgency situation for ACLF
  • Debate: Should LDLT be performed for alcohol-induced ACLF


LICAGE/Anesthesia/Critical Care Parallel Symposium: Pre-op

  • Peri-operative sodium and LT: Should we manage it or should we let it go?
  • Do we transplant patient with ACLF 3?
  • Timing of dialysis in AKI – early vs. late?
  • Cardiomyopathies in ESLD: Screening, management and contraindication for LT


Plenary Session I

  • Hyponatremia is associated with increased mortality in pediatric patients on the waiting list for liver transplantation
  • Radiomics to predict aggressive hepatocellular carcinoma features in liver transplantation
  • Delayed kidney transplant (KT) up to 2 days in combined liver-kidney transplantation (CLKT) offers similar renal function as KT alone: comparison analysis with mate kidneys
  • Proteinase3 contributes to hepatic ischemia reperfusion injury through promoting neutrophil inflammatory response
  • Liver transplant, liver resection or ablation as first-line treatment for solitary HCC 3 cm or less: an Intention-to-treat analysis
  • Reassessment of the risk of recurrence (R3) after liver transplantation for HCC: validation of the R3 score and comparison with existing models
  • Time-trends in patient mortality and graft survival of patients receiving a DCD or DBD liver transplantation in the UK and Ireland between 2008 and 2016
  • Post-normothermic perfusion sepsis: defining a new clinical syndrome
  • Utility and outcome of swap transplantation at a large volume living donor liver transplantation center


Featured Symposium: The Digital Liver Transplant Patient

  • Real-time quality assessment
  • Big Data? Big help or hype?
  • Robotics as an emerging technology in transplant surgery
  • Innovative applications for long-term quality control


Friday, May 7, 2021


LICAGE/Anesthesia/Critical Care Parallel Symposium: Intra-op

  • Prevention and management of intra-operative fibrinolysis: Controversy and new trends
  • Haemodynamic goals and intra-operative management of systemic hemodynamics
  • Intra-operative cardiac disasters
  • Intra-operative management of pulmonary hypertension


ELITA and TASL Joint Symposium I: HBV and Liver Transplantation

  • What is the role and rational for HBIG in prevention of HBV recurrence in 2021
  • Clinical case presentation
  • HBIG-free NA-based monoprophylaxis: Who and when?
  • Clinical case presentation
  • Key points of the ELITA HBV and LT Practice Guidelines
  • Clinical investigation in HBV LT candidates: Assessment of the evidence and future prospects


Parallel Session for Pediatrics I: Liver Transplantation for Pediatric Metabolic Liver Diseases

  • Management and indication of liver transplantation for urea cycle disease and organic acidemia
  • Liver transplantation in PFIC 1
  • Considerations for auxiliary liver transplantation in pediatric metabolic liver disease
  • Future treatment of metabolic liver disease using human iPS hepatic bud


Featured Symposium: Topics Without Consensus

  • Acute alcoholic hepatitis
  • Recreational drug use /opioid use in transplant patients
  • Obesity and frailty: Mutually exclusive?
  • Artificial liver support: a bridge or substitute to LT for acute liver failure


LICAGE/Anesthesia/Critical Care Parallel Symposium: Post-op

  • Management of failing graft
  • Graft-versus-host disease in LT – Something we can learn from bone marrow transplantation
  • Management of postoperative infections
  • Hemostatic changes in cirrhotic patients with sepsis


ELITA Symposium II: Acute on Chronic Liver Failure and LT

  • Introduction: ELITA CLIF European retrospective cohort on ACLF
  • The issue of futility: Are ACLF grade 3 patients too sick to be transplanted?
  • Prognosis of ACLF in patients listed for transplantation: Timing and implications for organ allocation in the MELD era
  • Surgical challenges in liver transplantation for ACLF: Is partial grafting (split and LDLT) a reasonable option?
  • ACLF in LT candidates: A challenge for intensivists and anesthesiologists


Parallel Session for Pediatrics II: Pediatric Liver Transplantation with Extrahepatic Involvements

  • When is liver and kidney transplantation a necessity in pediatric setting?
  • Fontan-associated liver cirrhosis: Role of the liver transplant surgeon
  • Encephalopathy and neuromonitoring in pediatric acute liver failure
  • Hepatopulmonary syndrome in pediatric liver transplantation


Plenary Session II

  • Predicting graft function after liver transplantation: validating the role of lactate at the end of transplant
  • Single-cell RNA sequencing reveals gene expression profiling of ischemia reperfusion injury
  • Sarco-model, a novel score to better predict the risk of death in cirrhotic patients awaiting liver transplantation
  • Pure laparoscopic versus open right hepatectomy in live liver donors: a propensity score matched analysis
  • Clonal evolution of recurrent hepatocellular carcinoma post-transplant and dependence on the immune environment
  • Myeloid-derived suppressor cells mobilization through CXCL1-CXCR2 signaling facilitates tumor recurrence after liver transplantation
  • CT based sarcopenia assessment & frailty scores are better than PELD in predicting early morbidity and mortality after pediatric live donor liver transplantation
  • The efficacy of ischemia-free liver transplantation in the treatment of end-stage liver disease in a prospective, randomized, controlled trial: a report of first 25 cases
  • Survival outcomes after liver transplantation for intrahepatic cholangiocarcinoma


Saturday, May 8, 2021


Featured Symposium: Transplant Oncology

  • Transplant immunology links to transplant oncology
  • Update on neoadjuvant strategies for liver cancer (CC and HCC)
  • Surgical perspective
  • New treatment options
  • Surgical resection
  • Transplant


Featured Symposium: Maintaining Excellence

  • What are the requirements of fellowship training: Lessons to learn from established transplant systems
  • Surgery
  • Hepatology
  • The effects of regulations on fellowship training – Panel discussion
  • Surgery
  • Hepatology
  • Critical Care/Anesthesia
  • What are the expectations of the trainees instructors and mentors? (Fellow perspective/Program director perspective)


Featured Symposium: Liver Transplantation in 2021

  • Does Meld/Na Meld remain a useful allocation system in 2021?
  • Protocols in immunosuppression after three decades: When and how?
  • What are new treatment options for Small for Size Syndrome in 2021?
  • Impact of liver donation on quality of life


Rising Star Plenary Session

  • Clinical and immunopathological features of two distinctive types of plasma-cell rich hepatitis: plasma-cell rich rejection and autoimmune hepatitis
  • Myosteatosis and its impact on graft- and patient survival in adult recipients of deceased donor liver transplantation
  • TLR4 induced PD-1 expression on myeloid dendritic cells promotes post-transplant HCC recurrence
  • Plasma microbiome profiles of liver transplant patients with operational tolerance
  • The beneficial intention-to-treat survival effect of living donation in patients with hepatocellular cancer waiting for liver transplantation

Please do not hesitate to contact us for further information about the program:

Scientific Secretariat

Jana Mruck
Phone: +49 30 24603 364
Email: scientific@2021.ilts.org


The official language of the Congress is English.